Thakur Bhawana, Anbalagan Amarnath Chellachamy, Koyande Pallavi, Sawant Shilpa N
Chemistry Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400085, India.
Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400094, India.
Sci Rep. 2025 May 15;15(1):16902. doi: 10.1038/s41598-025-99351-8.
Electrochemical surface plasmon resonance (ESPR) based biosensors play significant role in cancer detection due to its ability for real-time analysis and rapid detection. Herein, ESPR based biosensor was designed employing three different coupling strategies for the detection of cancer biomarker α-fetoprotein (AFP), a liver cancer biomarker. AFP antibody was immobilized on gold coated glass sensor disk using three different coupling strategies viz. (i) 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide / N-hydroxy succinamide (EDC/NHS), (ii) ethylene diamine/ glutaraldehyde (EDA/GA) and (iii) polyaniline/glutaraldehyde (PANI/GA) strategies. Among the three coupling strategies, immobilization via EDA/GA strategy afforded highest sensitivity (28°/(ng/ml)) with reasonable linear range (0.5-3 ng/ml) and whereas EDC/NHS strategy afforded wide linear range (5-70 ng/ml) with reasonable sensitivity (2.12°/(ng/ml). Immobilization efficiency and interaction steps involved in the sensor construction were investigated by electrochemical impedance spectroscopy. The sensor constructed using EDC/NHS strategy was validated by quantifying AFP in human blood serum samples, where the results are consistent with the values determined using ELISA. This fundamental study can help the researcher to choose the relevant coupling strategy for achieving desired sensor characteristics in clinical analysis of cancer biomarkers.
基于电化学表面等离子体共振(ESPR)的生物传感器因其能够进行实时分析和快速检测,在癌症检测中发挥着重要作用。在此,设计了基于ESPR的生物传感器,采用三种不同的偶联策略来检测癌症生物标志物甲胎蛋白(AFP),一种肝癌生物标志物。使用三种不同的偶联策略,即(i)1-乙基-3-[3-二甲氨基丙基]碳二亚胺/ N-羟基琥珀酰亚胺(EDC/NHS)、(ii)乙二胺/戊二醛(EDA/GA)和(iii)聚苯胺/戊二醛(PANI/GA)策略,将AFP抗体固定在涂金的玻璃传感器盘上。在这三种偶联策略中,通过EDA/GA策略固定化可提供最高灵敏度(28°/(ng/ml)),线性范围合理(0.5 - 3 ng/ml),而EDC/NHS策略提供较宽的线性范围(5 - 70 ng/ml),灵敏度合理(2.12°/(ng/ml))。通过电化学阻抗谱研究了传感器构建过程中涉及的固定化效率和相互作用步骤。使用EDC/NHS策略构建的传感器通过对人血清样本中的AFP进行定量验证,结果与使用酶联免疫吸附测定法(ELISA)测定的值一致。这项基础研究可以帮助研究人员选择相关的偶联策略,以便在癌症生物标志物的临床分析中实现所需的传感器特性。